$UNH · UNITEDHEALTH GROUP INC
UnitedHealth Group filed its Q3 2026 10-Q, reporting diluted EPS of $4.56 on revenue of $112.7B (-0.4% YoY). Net earnings attributable to common shareholders rose 75% to $4.11B, powered by a 150bp medical care ratio improvement to 88.4%. UnitedHealthcare membership declined by 1.8 million lives, while Optum revenues dipped 3%.
- Diluted EPS of $4.56 vs $2.59 a year ago — a 76% increase driven by sharply lower medical costs.
- Medical care ratio improved to 88.4% from 89.9%, reflecting $2.98B less in medical costs on 2% lower premiums.
- UnitedHealthcare shed 1.8 million members due to benefit design changes, Medicaid redeterminations, and exiting one state.
- Operating cash flow reached $25.1B for the nine months, up from $18.6B in the prior-year period.
- Share repurchases totaled $5.0B year-to-date; shares outstanding fell from 906M to 896M.
Extended-hours trading shows minimal movement at $404.28 (-0.04% vs regular close), suggesting the strong earnings beat was largely priced in or offset by the 1.8M membership decline. The $363B market cap limits dramatic percentage swings on a single quarter.
The 76% EPS surge on declining revenue reveals a managed-care giant trading volume for margin — a strategic pivot with major implications for the entire health insurance sector.
The medical cost ratio improvement to 88.4% mirrors a broader managed-care trend of favorable utilization post-pandemic, though UNH's membership losses contrast with peers who are growing exchange and Medicare Advantage books. The $25.1B operating cash flow underscores the sector's cash-generation resilience even amid top-line pressure.
Membership erosion of 1.8M lives at UnitedHealthcare signals ongoing headwinds from Medicaid redeterminations and competitive pricing pressures. Unrealized losses on available-for-sale debt securities widened to $3.6B (from $1.6B at year-end 2025), compressing accumulated other comprehensive loss to $3.9B.